Breaking News Instant updates and real-time market news.

T

AT&T

$39.36

0.14 (0.36%)

14:58
10/17/16
10/17
14:58
10/17/16
14:58

AT&T looking to expand in music business, NY Post says

According to a NY Post article published over the weekend, AT&T "is in big-time acquisition mode and is focusing its efforts on the music business." Sources told the Post that the telecom giant and owner of DirecTV, "is working on a plan to get much bigger. " A music industry source said, "All the tech companies are trying to figure out the entertainment space," according to the Post article. Reference Link

  • 24

    Oct

T AT&T
$39.36

0.14 (0.36%)

09/28/16
UBSW
09/28/16
DOWNGRADE
Target $43
UBSW
Neutral
AT&T downgraded to Neutral from Buy at UBS
UBS analyst John Hodulik downgraded AT&T to Neutral citing expectations for lower earnings growth. The analyst reduced his earnings estimates by 3% to reflect the "increased competitive intensity" in wireless and incremental costs associated with AT&T's DTV Now roll-out. Hodulik cut his price target for AT&T shares to $43 from $46.
09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
FBNS
10/06/16
INITIATION
Target $69.24
FBNS
Outperform
AMC Networks initiated with an Outperform at FBN Securities
FBN Securities analyst Robert Routh initiated AMC Networks (AMCX) with an Outperform rating and a fair value estimate of $69.24. Routh calls AMC Networks "very attractive" as a possible takeover target, as he believes it could fit well with either the soon-to-be-combined Lionsgate (LGF)-Starz (STRZA) or with AT&T's (T) DTV division. Routh added that reports have indicated that AT&T is looking to grow its portfolio of TV content through deals.
10/11/16
DBAB
10/11/16
NO CHANGE
Target $45
DBAB
Buy
AT&T pullback brings attractive buying opportunity, says Deutsche Bank
After hosting investor meetings with management, Deutsche Bank analyst Matthew Niknam says the recent pullback in shares of AT&T presents an attractive buying opportunity. The analyst tells investors that he left the meetings more bullish on AT&T's competitive positioning given its "leading scale and more efficient cost structure across distribution platforms." He reiterates a Buy rating on the shares with a $45 price target.

TODAY'S FREE FLY STORIES

RDUS

Radius Health

$38.72

-0.5 (-1.27%)

10:07
04/28/17
04/28
10:07
04/28/17
10:07
Hot Stocks
Radius Health jumps after FDA posts approval of Tymlos 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 03

    May

  • 02

    Jun

  • 30

    Jun

ORLY

O'Reilly Automotive

$257.19

-7.88 (-2.97%)

10:02
04/28/17
04/28
10:02
04/28/17
10:02
Recommendations
O'Reilly Automotive analyst commentary  »

O'Reilly Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

MHK

Mohawk

$229.91

-8.97 (-3.76%)

10:01
04/28/17
04/28
10:01
04/28/17
10:01
Technical Analysis
Mohawk testing uptrend support line following earnings »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

10:01
04/28/17
04/28
10:01
04/28/17
10:01
General news
Consumer Sentiment Index data reported »

April Consumer Sentiment…

CL

Colgate-Palmolive

$72.10

-1.2 (-1.64%)

10:01
04/28/17
04/28
10:01
04/28/17
10:01
Options
Call buyer in Colgate as shares fall on earnings »

Call buyer in Colgate as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 31

    May

EEX

Emerald Expositions Events

10:00
04/28/17
04/28
10:00
04/28/17
10:00
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

IVC

Invacare

$14.85

1.6 (12.08%)

09:59
04/28/17
04/28
09:59
04/28/17
09:59
Upgrade
Invacare rating change  »

Invacare upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 18

    May

CVNA

Carvana

09:58
04/28/17
04/28
09:58
04/28/17
09:58
Syndicate
Breaking Syndicate news story on Carvana »

Carvana opens at $13.50,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

EFX

Equifax

$134.84

-1.35 (-0.99%)

09:56
04/28/17
04/28
09:56
04/28/17
09:56
Downgrade
Equifax rating change  »

Equifax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 04

    May

EEX

Emerald Expositions Events

09:55
04/28/17
04/28
09:55
04/28/17
09:55
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

09:55
04/28/17
04/28
09:55
04/28/17
09:55
General news
U.S. Chicago PMI increased 0.6 points to 58.3 in April »

U.S. Chicago PMI…

CSGP

CoStar Group

$236.71

17.35 (7.91%)

09:53
04/28/17
04/28
09:53
04/28/17
09:53
Recommendations
CoStar Group analyst commentary  »

CoStar Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

BOKF

BOK Financial

$85.04

-0.42 (-0.49%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Upgrade
BOK Financial rating change  »

BOK Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

OCLR

Oclaro

$7.93

0.01 (0.13%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Recommendations
Oclaro analyst commentary  »

Oclaro estimates lowered …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 30

    May

BSX

Boston Scientific

$26.16

-0.02 (-0.08%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Options
Active trading in Boston Scientific short-term calls »

Active trading in Boston…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 07

    Jun

  • 27

    Jun

EEX

Emerald Expositions Events

09:50
04/28/17
04/28
09:50
04/28/17
09:50
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

09:50
04/28/17
04/28
09:50
04/28/17
09:50
General news
The hefty 0.8% U.S. Q1 ECI gain »

The hefty 0.8% U.S. Q1…

ZYME

Zymeworks

09:49
04/28/17
04/28
09:49
04/28/17
09:49
Syndicate
Breaking Syndicate news story on Zymeworks »

Zymeworks opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

XRF

China Rapid Finance

09:48
04/28/17
04/28
09:48
04/28/17
09:48
Syndicate
Breaking Syndicate news story on China Rapid Finance »

China Rapid Finance opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

ALGN

Align Technology

$120.09

0.35 (0.29%)

09:48
04/28/17
04/28
09:48
04/28/17
09:48
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

CVNA

Carvana

09:47
04/28/17
04/28
09:47
04/28/17
09:47
Syndicate
Breaking Syndicate news story on Carvana »

Carvana IPO indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

CLDR

Cloudera

09:47
04/28/17
04/28
09:47
04/28/17
09:47
Syndicate
Cloudera IPO indicated to open at $14 on 1.3M shares »

Cloudera (CLDR) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

09:46
04/28/17
04/28
09:46
04/28/17
09:46
General news
Chicago PMI Business Barometer Index data reported »

April Chicago PMI…

09:45
04/28/17
04/28
09:45
04/28/17
09:45
General news
U. Michigan sentiment preview: »

U. Michigan sentiment…

09:45
04/28/17
04/28
09:45
04/28/17
09:45
General news
Consumer Sentiment Index to be reported at 10:00 »

April Consumer Sentiment…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.